En Es
Categories

Mobidiag Ltd.

Mobidiag is a biotechnology company specializing in developing and marketing solutions for molecular diagnostics of infectious diseases. Its products use well-established multiplex real-time PCR technology, ensuring optimal performance, suitability for high-volume screening use and cost-effectiveness in mid-sized to larg ...
Products Covid-19NewsSummary
Close

Covid-19 Mobidiag Ltd.

Clinical Laboratory

SARS-CoV-2, Flu A/B, RSV Test
Amplidiag RESP-4

The Amplidiag RESP-4 test allows for the rapid detection of novel coronavirus, Flu A, Flu B and RSV infections. By allowing rapid and reliable detection of the viruses responsible for these infections simultaneously, the qualitative real-time RT-PCR test supports decisions to manage efficiently epidemiological and infection control measures, isolate patients in a timely manner and improve patient care.
More details

Anti-SARS-CoV-2 Rapid Test
Anti-SARS-CoV-2 Rapid Test

The Anti-SARS-CoV-2 Rapid Test is based on a colloidal gold method for the rapid, qualitative determination of Anti-SARS-CoV-2 (IgG/IgM antibodies of Severe Acute Respiratory Syndrome Coronavirus 2) in human serum, plasma or whole blood. The assay is based upon one-step capture method and contains a membrane, which is pre-coated with two mouse anti-human monoclonal antibodies (anti-IgG and anti-IgM) on two separated test lines.
More details

COVID-19 Test
Novodiag COVID-19 test

The Novodiag COVID-19 test operates using the on demand rapid ‘sample-in, result-out’ Novodiag system, allowing for the rapid detection of novel coronavirus in about one hour. The fully automated solution protects laboratory staff from potential contamination and can be delivered to high risk and hard to reach areas, as well as decentralized laboratories, without the need for highly trained personnel.
More details

COVID-19 Test
Amplidiag COVID-19 test

The Amplidiag COVID-19 test allows for the rapid and reliable detection of novel coronavirus for large volumes (by batch). The qualitative real-time RT-PCR test supports decisions to manage efficiently epidemiological and infection control measures, isolate patients in a timely manner and improve patient care.
More details
Close

News of Mobidiag Ltd.

Hologic to Acquire Mobidiag to Strengthen Diagnostic Testing Business

09 Apr 2021
Hologic to Acquire Mobidiag to Strengthen Diagnostic Testing Business
Hologic, Inc. (Marlborough, MA, USA) has signed a definitive agreement to acquire Mobidiag Ltd. (Espoo, Finland) in a USD 795 million transaction that will accelerate the global growth of Mobidiag’s differentiated molecular platform, which offers ease of use, multiplex capability and rapid turnaround time.
Read More
Close

About Mobidiag Ltd.

Mobidiag is a biotechnology company specializing in developing and marketing solutions for molecular diagnostics of infectious diseases. Its products use well-established multiplex real-time PCR technology, ensuring optimal performance, suitability for high-volume screening use and cost-effectiveness in mid-sized to large laboratory settings.
FaceBook Twitter Google+ Linked in
Anti-SARS-CoV-2 Rapid Test

Anti-SARS-CoV-2 Rapid Test

Model: Anti-SARS-CoV-2 Rapid Test
Request Information

Description:

The Anti-SARS-CoV-2 Rapid Test is based on a colloidal gold method for the rapid, qualitative determination of Anti-SARS-CoV-2 (IgG/IgM antibodies of Severe Acute Respiratory Syndrome Coronavirus 2) in human serum, plasma or whole blood. The assay is based upon one-step capture method and contains a membrane, which is pre-coated with two mouse anti-human monoclonal antibodies (anti-IgG and anti-IgM) on two separated test lines.


Send A Message To This Supplier

* Required Information
* Email
To
Mobidiag Ltd. (Anti-SARS-CoV-2 Rapid Test)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions